🎉We have received funding from @kwf_nl for a large randomized trial investigating upfront dose-reduced #chemotherapy in #older patients with metastatic colorectal cancer! 🎉 @NienkedeGlas @JoPortielje @LUMC_Leiden #LUMC

RT @JGeriOnc: Systemic treatment among frail older patients with cancer: An observational cohort @WilliamDale_MD @m…

RT @JGeriOnc: Treatment outcomes in older patients presenting to a radiation oncology clinic based on an electronic health record-based fra…

RT @EnriqueSoto8: Glad to see the wonderful SONIA trial published in Nature! #bcsm Great data to guide treatment decision making and health…

RT @EnriqueSoto8: @OncJournal @SIOGorg @CancerCareMASCC @JCBaltussen @UniLeidenNews @CUCancerCenter @INCMNSZ_Geria The most commonly measur…

RT @EnriqueSoto8: Our systematic review on the use of #wearable technologies in older adults with #cancer is out in @OncJournal #gerionc #g…

⌚️📱Wearables show great potential in geriatric oncology care, but an overview of their use was lacking-until now! 🚨Just published in @OncJournal : our systematic review on wearables in older adults with cancer, including recommendations @EnriqueSoto8

RT @selcukorkmaz: Understanding the difference between Standard Deviation (SD) and Standard Error (SE) is crucial for accurate data interpr…

@abe_verghese Just finished your book and I loved every page of it! Made me realize how grateful I am to work as a doctor and to be able use all your senses in caring for your patients 👀 👃 👂 🧬 And it brought me back to my trip to the Kerala backwaters

@chefaleixomd @ramsedhom @ravi_b_parikh @GrantWilliamsMD Interesting findings!🔥 I think it also shows the need for RCTs to investigate the ‘start low, go slow’ approach in older adults, as observational studies are heavily confounded by frailty

RT @oncology_bg: Oncologists’ perceptions of PFS. These quotes are gold.

RT @SIOGorg: 📅 Save the Date! SIOG’s Research Masterclass on Geriatric Oncology March 19 - 21, 2025! Expand your study toolkit & profession…

RT @JGeriOnc: Association of Glasgow Prognostic Score with frailty, mortality and adverse health outcomes in older patients with cancer: A…

🚀 Already looking forward to the results of the IMPORTANT-trial, investigating lower starting doses of #CDK4/6 inhibitors and the role of the #geriatric assessment in older adults with mBC Congratulations to the authors for enrolling this study!

RT @YoungSIOG: Meet the new YSIOG Governance Team of 2024-2026! 2️⃣0️⃣2️⃣4️⃣-2️⃣0️⃣2️⃣6️⃣

RT @Decoster_Lore: Happy to invite you all to the beautiful city of Ghent for the 2025 Annual meeting of SIOG. #SIOG2024

RT @geriatric_onc: Amazing work from Young SIOG members with research with 61 articles published. Keep up the great work @YoungSIOG @SIOGor…

RT @FabioGomes_Go: 🍁🇨🇦 Great gathering by @YoungSIOG in Montreal for #SIOG2024 . Thanks everyone for joining and big thanks to the 2022-202…

@Dr_F_Coutinho @IndiaPinker @SIOGorg Thanks @IndiaPinker for all the great work!!

RT @Dr_F_Coutinho: Great work from @IndiaPinker . Very happy to be part of talented team. Congrats! @SIOGorg Annual Conference #SIOG2024 h…

@JGeriOnc @SurbhiSinghalMD @melisawongmd @WilliamDale_MD @rochgerionc @myCARG Great paper! 🚀 Would be interesting to further characterize those older patients that remain stable or are able to recover after treatment #resilience